TABLE 1.
Outcome | [177Lu]Lu-DOTA-trastuzumab (10 MBq) (n = 9) | [177Lu]Lu-DOTA-trastuzumab (5 MBq) (n = 8) | [177Lu]Lu-DOTA-trastuzumab (5 MBq) + regimen 3 (n = 8) |
---|---|---|---|
Objective response | 5 | 1 | 5 |
Stable disease | 1 | 4 | 3 |
Progressive disease | 3 | 3 | 0 |
Outcome | [177Lu]Lu-DOTA-trastuzumab (10 MBq) (n = 9) | [177Lu]Lu-DOTA-trastuzumab (5 MBq) (n = 8) | [177Lu]Lu-DOTA-trastuzumab (5 MBq) + regimen 3 (n = 8) |
---|---|---|---|
Objective response | 5 | 1 | 5 |
Stable disease | 1 | 4 | 3 |
Progressive disease | 3 | 3 | 0 |